milrinone has been researched along with von Hippel-Lindau Disease in 1 studies
von Hippel-Lindau Disease: An autosomal dominant disorder caused by mutations in a tumor suppressor gene. This syndrome is characterized by abnormal growth of small blood vessels leading to a host of neoplasms. They include HEMANGIOBLASTOMA in the RETINA; CEREBELLUM; and SPINAL CORD; PHEOCHROMOCYTOMA; pancreatic tumors; and renal cell carcinoma (see CARCINOMA, RENAL CELL). Common clinical signs include HYPERTENSION and neurological dysfunctions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lam, H | 1 |
| Nguyen, T | 1 |
| Austin, T | 1 |
1 other study available for milrinone and von Hippel-Lindau Disease
| Article | Year |
|---|---|
Recurrent cardiomyopathy from recurrent pheochromocytoma in a pediatric patient.
Topics: Adrenal Gland Neoplasms; Cardiomyopathies; Cardiotonic Agents; Child; Humans; Male; Milrinone; Pheoc | 2014 |